Skip Navigation


Carcinogenesis Advance Access originally published online on June 5, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/8/1407    most recent
bgg094v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Liu, E. S.L.
Right arrow Articles by Cho, C.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, E. S.L.
Right arrow Articles by Cho, C.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 8, 1407-1413, August 2003
© 2003 Oxford University Press


CARCINOGENESIS

Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice

Edgar S.L. Liu1, Yi-Ni Ye1,4, Vivian Y. Shin1, Siu-Tsan Yuen2, Suet-Yi Leung2, Benjamin C.Y. Wong3 and Chi-Hin Cho1,5

1 Department of Pharmacology, Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China
2 Department of Pathology, Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China
3 Department of Medicine, Faculty of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China
4 Department of Pharmacology, Faculty of Medicine, Zhejiang University, Hangzhou, People's Republic of China

5 To whom correspondence should be addressed Email: chcho{at}hkusua.hku.hk

Both chronic ulcerative colitis and smoking are associated with colorectal cancer in humans. In the present study, we investigated the effects of cigarette smoke (CS) exposure on inflammation-associated tumorigenesis in the mouse colon. Male balb/c mice were allocated into six groups: control, CS (2%), CS (4%), colitis, colitis + CS (2%) and colitis + CS (4%). They were given water or 3% dextran sulfate sodium (DSS) in drinking water for 7 days to induce colitis, with or without 1 h daily exposure to 2 or 4% CS. They were then allowed to drink water for 14 days. The cycle of 7 day DSS ± CS/14 day H2O treatments were repeated twice. Mice were killed immediately or 1 month after the three cycles of treatments. Results indicated colonic adenoma was only found in the colitis group (one out of 11), Colitis + CS (2%) group (seven out of 12) and colitis + CS (4%) group (four out of five) 1 month after three cycles of DSS and/or CS treatment. CS exposure dose-dependently increased adenoma formation in mice with inflamed mucosa. CS exposure plus colitis was strongly associated with a high incidence of dysplasia (P < 0.01) and adenocarcinoma formation (P < 0.01) compared with induction of colitis alone. Colitis induced cell proliferation and apoptosis in colonic tissues. Cigarette smoking significantly attenuated the apoptotic effect by DSS probably via the induction of anti-apoptotic protein bcl-2. The ratio of apoptosis over proliferation was also significantly lower in the colitis + CS groups. Vascular endothelial growth factor and angiogenesis in the colon were also increased by cigarette smoking in animals with colitis. In conclusion, CS promotes inflammation-associated adenoma/adenocarcinoma formation in the mouse colon in a dose-dependent manner. This tumor development is associated with the inhibition of cellular apoptosis and supported by increased angiogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
E. K. K. Tai, W. K. K. Wu, H. P. S. Wong, E. K. Y. Lam, L. Yu, and C. H. Cho
A New Role for Cathelicidin in Ulcerative Colitis in Mice
Experimental Biology and Medicine, June 1, 2007; 232(6): 799 - 808.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S. Danese, M. Sans, D. M Spencer, I. Beck, F. Donate, M. L Plunkett, C. de la Motte, R. Redline, D. E Shaw, A. D Levine, et al.
Angiogenesis blockade as a new therapeutic approach to experimental colitis
Gut, June 1, 2007; 56(6): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. K. S. Ko and C.-H. Cho
The Diverse Actions of Nicotine and Different Extracted Fractions from Tobacco Smoke against Hapten-Induced Colitis in Rats
Toxicol. Sci., September 1, 2005; 87(1): 285 - 295.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.N. Ye, W.K.K. Wu, V.Y. Shin, I.C. Bruce, B.C.Y. Wong, and C.H. Cho
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
Carcinogenesis, April 1, 2005; 26(4): 827 - 834.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. C. Luo, V. Y. Shin, Y. H. Yang, W. K. K. Wu, Y. N. Ye, W. H. L. So, F. Y. Chang, and C. H. Cho
Tumor necrosis factor-{alpha} stimulates gastric epithelial cell proliferation
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G32 - G38.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. N. Ye, E. S. L. Liu, V. Y. Shin, W. K. K. Wu, J. C. Luo, and C. H. Cho
Nicotine Promoted Colon Cancer Growth via Epidermal Growth Factor Receptor, c-Src, and 5-Lipoxygenase-Mediated Signal Pathway
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 66 - 72.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.